NCT01038297 - Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2009

Primary Completion Date

July 7, 2010

Study Completion Date

July 7, 2010

Conditions

Scar Prevention

Interventions

DRUG

EXC 001

Intradermal injections of EXC 001 and placebo given on various schedules.

DRUG

Placebo

Intradermal injections of EXC 001 and placebo given on various schedules.

Trial Locations (2)

Northwestern University,Division of Plastic Surgery, Chicago

Body Aesthetic Plastic Surgery, St Louis